SummitMD

Angioplasty Summit 2004 > Syllabus

Welcome

Course Director

Poster Abstracts -
Guideline -


Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.

The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy.

A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis.

Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection.

Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients.

Multicenter randomized comparison of direct vs. conventional stenting: the DIRECTO trial.

In-stent stenosis: pathology and implications for the development of drug eluting stents.

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

Direct coronary stenting without balloon predilation of lesions requiring long stents: immediate and 6-month results of a multicenter prospective registry.

Pilot trial of oral rapamycin for recalcitrant restenosis.

Direct stent implantation without predilatation through 5 French guiding catheter following transfemoral coronary angiogram: A feasibility study.

Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial.

Comparison of outcomes (early and six- month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials).

Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?

Use of restenting should be minimized with intracoronary radiation therapy for in-stent restenosis.

Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty.

Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population.

Sarpogrelate treatment reduces restenosis after coronary stenting.

Silicon carbide-coated stents in patients with acute coronary syndrome.

Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients.

Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis.

Low restenosis rate of the NIR coronary stent: results of the Danish multicenter stent study (DANSTENT)--a randomized trial comparing a first-generation stent with a second-generation stent.

Usefulness of a cobalt chromium coronary stent alloy.

Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis*1.

Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH).

Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial.

Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.

Gender and restenosis after coronary artery stenting.

Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.

Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.

A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.

Incidence and predictors of late total occlusion following coronary stenting.

Prospective randomized comparison of early and late results of 4 different stent designs.

Influence of residual stenosis after percutaneous coronary intervention with stent implantation on development of restenosis and stent thrombosis.

Comparison of outcomes in women and men treated with coronary stent implantation.

Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.

Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome.

Impact of the acute results on the long-term outcome after the treatment of in-stent restenosis: a serial intravascular ultrasound study.

Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting.

Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease. A meta-analysis of randomized controlled trials.

Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting.

Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study.